Skip to main content
Blog
Open App →

AIRESCAN Stock Review (8/8/2022)

AIRESCAN Stock Review (8/8/2022)

Hi everyone.

On 08/08/2022, our system had provided a few picks and the results are as below:

CHWY  – (Buy)  Withdrawn

CRSP – (Buy)  Profit

All three major US stock indexes pared earlier gains on Monday with S&P 500 and Nasdaq closing in the red as another big revenue warning in the semiconductor sector hit technology, and as investors position ahead of this week’s key inflation report. 

Let’s review our stock picks on Monday.

Call for buy for CHWY which was withdrawn but the call was made in the right direction. Our system withdrew because the price opened with a gap above our EP before trading upwards throughout the market.

Chewy, Inc., together with its subsidiaries, engages in the pure play e-commerce business in the United States. The company provides pet food and treats, pet supplies and pet medications, and other pet-health products, as well as pet services for dogs, cats, fish, birds, small pets, horses, and reptiles through its www.chewy.com retail Website, as well as its mobile applications. 

Call for sell for CRSPR which resulted in a profit. Our system gave a call to enter at $81.76 and take profit at $83.80. If you followed this stock, you would gain a profit of 2.5%. 

CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA. The company has a portfolio of therapeutic programs across a range of disease areas, including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. 

Stay tuned for more of our stock picks.

Want the next pick before it's written up?

AIRESCAN's AI publishes live recommendations in the app.

Open the app →